Literature DB >> 15701041

Right arm ischemia following intentional stent-graft coverage of an anomalous right subclavian artery.

Matthew Waltham1, Ves Agrawal, Leigh Bowman, Clifford Hughes, Geoffrey H White.   

Abstract

PURPOSE: To report thoracic aortic stent-graft repair in a patient with abnormal aortic arch anatomy. CASE REPORT: An anomalous right subclavian artery was covered with a stent-graft in a 38-year-old woman being treated for a false aneurysm after coarctation repair. The right arm became relatively ischemic, but was viable and managed conservatively.
CONCLUSIONS: Aneurysms close to left or aberrant right subclavian arteries can be safely and effectively treated by endoluminal repair without the need for revascularization procedures; ischemic symptoms that develop are often mild and transient.

Entities:  

Mesh:

Year:  2005        PMID: 15701041     DOI: 10.1583/04-1374R.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  4 in total

1.  Transesophageal echocardiography and intraoperative phlebotomy during surgical repair of coarctation of aorta in a patient with atrial septal defect, moderately severe mitral regurgitation and severe pulmonary hypertension.

Authors:  Praveen Kumar Neema; Subrata K Singha; S Manikandan; Ramesh Chandra Rathod
Journal:  J Clin Monit Comput       Date:  2012-05-04       Impact factor: 2.502

2.  Interactive virtual stent planning for the treatment of coarctation of the aorta.

Authors:  Mathias Neugebauer; Martin Glöckler; Leonid Goubergrits; Marcus Kelm; Titus Kuehne; Anja Hennemuth
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-05-16       Impact factor: 2.924

Review 3.  The adult with repaired coarctation of the aorta.

Authors:  Eric M Horlick; Peter R McLaughlin; Lee N Benson
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

4.  Use of covered stents to treat coarctation of the aorta.

Authors:  Shakeel Ahmed Qureshi
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.